Determination and quantification of nine adulterant local anaesthetics in illegal treatments for male premature ejaculation by GC-FID and GC-MS

Authors

  • Ji Hyun Lee
  • So- Hyun Cho
  • Jung Yeon Kim
  • Hyoung Joon Park
  • Jung-ah Do
  • Sunyoung Baek Advanced Analysis Team, Toxicological Evaluation and Research Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju-si, Chungcheongbuk-do 363700, Korea

Abstract

Objective: A gas chromatography (GC) method using flame ionization (FID) and mass spectrometry (MS) was developed and validated for the determination of nine local anaesthetics in counterfeit drugs sold illegally as treatments for male premature ejaculation.

Methods: The GC-FID and GC-MS method validations demonstrated reliable specificity, selectivity, linearity, precision, and accuracy, and the validated methods were successfully applied to the analyses of collected samples.

Results: Approximately 60% of the samples contained, at least, one of the local anaesthetics, which included menthol, 2-phenoxyethanol, eugenol, lidocaine, prilocaine, and tetracaine. Lidocaine was the most frequently detected compound in the analysed samples and occurred in a wide concentration range (2.81–52.40 mg/g). The concentrations of the detected compounds varied greatly between 0.03–52.40 mg/g.

Conclusion: Continuous use of these counterfeit products, which contain high concentrations of local anaesthetics, can cause serious human health effects. Therefore, the continued screening of illegal products is required and our proposed methods could be used for the monitoring and quantification of local anaesthetics in counterfeit products.

Keywords: Local anesthetics, Premature ejaculation, GC/FID, GC/MS, Adulterants, Validation.

Downloads

Download data is not yet available.

References

Henry R, Morales A. Topical lidocaine-prilcaine spray for the treatment of premature ejaculation: a proof of concept study. Int J Impotence Res 2003;15:277-81.

Laumann EO, Paik A, Rosen C. Sexual dysfunction in the united states: prevalence and predictors. JAMA 1999;281:537-45.

Hanzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-14.

Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviours. Int J Impotence Res 2005;17:39-57.

Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol 2007;51:816-24.

Orsi DD, Pellegrini M, Marchei E, Nebuloni P, Gallinella B, Scaravelli G, et al. High performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of vardenafil, sildenafil, tadalafil, testosterone and local anesthetics in cosmetics sold on the Internet web site. J Pharm Biomed Anal 2009;50:362-9.

Pellegrini M, Marchei E, Pacifici R, Rotolo MC, Pichini S. Advances in the analysis of non-allowed pharmacologically active substances in cosmetic products. J Pharm Biomed Anal 2011;55:842-7.

Orsi DD, Pellegrini M, Pichini S, Mattioli D, Marchei E, Gagliardi L. High-performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of non-allowed substances in cosmetic products for preventing hair loss and other hormone-dependent skin diseases. J Pharm Biomed Anal 2008;48:641-8.

Gaudiano MC, Lucent D, Antoniella E, Bertocchi P, Muleri N, Manna L, et al. For export only medicines come back to Europe: a RP-LC method for the screening of six glucocorticoids in illegal and counterfeit anti-inflammatory and lightening creams. J Pharm Biomed Anal 2010;53:158-64.

Gagliardi L, Orisi DD, Chimenti P, Porra R, Tonelli D. HPLC determination of imidazole antimycotis on antidandruff cosmetic products. Anal Sci 2003;19:1195-7.

Fijalek Z, Sarna L, Blazewicz A, Maurin J, Baran P, Waclawek K. Counterfeit medicinal products, medical devices and dietary supplements-growing safety risks for public health. Military Pharm Med 2011;4:29-39.

Wunder C, Meier J, Reyher C, Konitz V, Paulke A, Zacharowski K, et al. Use of lidocaine in endotracheal intubation. Blood and urine concentrations in patients and deceased after unsuccessful resuscitation. Forensic Sci Int 2014;244:259-62.

Floriani G, Gasparetto JC, Pontarolo R, Goncalves AG. Development and validation of an HPLC-DAD method for simultaneous determination of cocaine, benzoic acid, benzoylecgonine and the main adulterants found in products based on cocaine. Forensic Sci Int 2014;235:32-9.

Porra R, Berri S, Gagliardi L, Chimenti P, Granese A, Orsi DD, et al. Development of an HPLC method for the identification and dosage of non-allowed substances in cosmetic products. Part â… : local anesthetics and antihistaminics. Anal Bioanal Chem 2004;380:767-72.

ICH Q2A validation of analytical methods definitions and terminology. International Conference on Harmonisation IFPMA Geneva; 1994.

ICH Q2B validation of analytical procedures: methodology (CPMP/ICH/281/95). International Conference on Harmonisation IFPMA Geneva; 1995.

ICH Q2 (R1) harmonised tripartite guideline, validation of analytical procedures: test and methodology. International Conference on Harmonisation IFPMA Geneva; 2005.

Published

01-03-2016

How to Cite

Lee, J. H., S.-. H. Cho, J. Y. Kim, H. J. Park, J.- ah Do, and S. Baek. “Determination and Quantification of Nine Adulterant Local Anaesthetics in Illegal Treatments for Male Premature Ejaculation by GC-FID and GC-MS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 3, Mar. 2016, pp. 135-40, https://www.innovareacademics.in/journals/index.php/ijpps/article/view/7686.

Issue

Section

Original Article(s)